| Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin DPPRG WC Knowler, E Barrett-Connor, SE Fowler, RF Hamman New England Jorunal of Medicine 346 (6), 393-403, 2002 | 25251* | 2002 |
| 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study WC Knowler, SE Fowler, RF Hamman, CA Christophi, HJ Hoffman, ... Lancet 374 (9702), 1677, 2009 | 3532 | 2009 |
| The Diabetes Prevention Program (DPP): description of lifestyle intervention Diabetes Prevention Program Research Group Diabetes Care 25 (12), 2165-2171, 2002 | 2018 | 2002 |
| Effect of weight loss with lifestyle intervention on risk of diabetes RF Hamman, RR Wing, SL Edelstein, JM Lachin, GA Bray, L Delahanty, ... Diabetes care 29 (9), 2102-2107, 2006 | 1628 | 2006 |
| The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial TJ Orchard, M Temprosa, R Goldberg, S Haffner, R Ratner, S Marcovina, ... Annals of internal medicine 142 (8), 611, 2005 | 1268 | 2005 |
| TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program JC Florez, KA Jablonski, N Bayley, TI Pollin, PIW de Bakker, AR Shuldiner, ... New England Journal of Medicine 355 (3), 241-250, 2006 | 1126 | 2006 |
| Design and methods for a clinical trial in the prevention of type 2 diabetes TDP Program Diabetes Care 22 (4), 623-634, 1999 | 1038* | 1999 |
| Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions RE Ratner, CA Christophi, BE Metzger, D Dabelea, PH Bennett, ... The Journal of Clinical Endocrinology & Metabolism 93 (12), 4774-4779, 2008 | 1036 | 2008 |
| Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program … Diabetes Prevention Program Research Group The lancet Diabetes & endocrinology 3 (11), 866-875, 2015 | 949 | 2015 |
| Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies SL Edelstein, WC Knowler, RP Bain, A Reubin, EL Barrett-Connor, ... Diabetes 46 (4), 701, 1997 | 920 | 1997 |
| The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance WH Herman, TJ Hoerger, M Brandle, K Hicks, S Sorensen, P Zhang, ... Annals of internal medicine 142 (5), 323, 2005 | 869 | 2005 |
| Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program Diabetes Prevention Program Research Group Diabetes care 28 (4), 888-894, 2005 | 767 | 2005 |
| Diabetes Prevention Program Research Group Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program WH Herman, Y Ma, G Uwaifo, S Haffner, SE Kahn, ES Horton, JM Lachin, ... Diabetes Care 30 (10), 2453-2457, 2007 | 727* | 2007 |
| Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children TO Kilpeläinen, L Qi, S Brage, SJ Sharp, E Sonestedt, E Demerath, ... PLoS medicine 8 (11), e1001116, 2011 | 724 | 2011 |
| Achieving weight and activity goals among diabetes prevention program lifestyle participants Diabetes Prevention Program Research Group Obesity research 12 (9), 1426-1434, 2004 | 624 | 2004 |
| Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study VR Aroda, SL Edelstein, RB Goldberg, WC Knowler, SM Marcovina, ... The Journal of Clinical Endocrinology & Metabolism 101 (4), 1754-1761, 2016 | 620 | 2016 |
| Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. WC Knowler, RF Hamman, SL Edelstein, E Barrett-Connor, DA Ehrmann, ... Diabetes 54 (4), 1150, 2005 | 581* | 2005 |
| Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin AE Kitabchi, M Temprosa, WC Knowler, SE Kahn, SE Fowler, SM Haffner, ... Diabetes 54 (8), 2404, 2005 | 571 | 2005 |
| Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study L Perreault, Q Pan, KJ Mather, KE Watson, RF Hamman, SE Kahn The Lancet, 2012 | 555 | 2012 |
| The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS Diabetes Prevention Program Research Group Diabetes Care 35 (4), 723-30, 2012 | 512 | 2012 |
